Proximity Work in Family Medicine Groups : the Impact of Pharmacists

Laval University1 site in 1 country62 target enrollmentAugust 2015

ConditionsHealth Services

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Health Services
Sponsor: Laval University
Enrollment: 62
Locations: 1
Primary Endpoint: Number of drug related problems
Status: Completed
Last Updated: 9 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The project objective is to evaluate the impact of the recent addition of pharmacists within family medicine groups (FMGs) on organizational and clinical parameters. The process by which changes occur and the level of pharmacists' activities will also be assessed. The ultimate goal of the project is the development of an accompanying guide to facilitate the work of the pharmacist in monitoring complex patients in primary care medical clinics.

Registry

clinicaltrials.gov

Start Date

August 2015

End Date

April 2016

Last Updated

9 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Laval University

Responsible Party

Principal Investigator

Line Guénette

Assistant professor

Laval University

Eligibility Criteria

Inclusion Criteria

•Willing to meet with the pharmacist and;
•Consuming drugs of four or more different pharmacological classes or having to take at least four doses per day and;
•aged 70 or over with at least two criteria of vulnerability or aged less than 70 with at least 3 criteria of vulnerability or had a recent loss of autonomy or in post- hospitalization with medication changes in the hospital.

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

Number of drug related problems

Time Frame: 3 to 6 months

Secondary Outcomes

Medication adherence(3 to 6 months)
Regimen complexity(3 to 6 months)
Quality of care provided by the clinical team (pharmacists, doctors, nurses, etc.)(3 to 6 months)